Skip to Content

Aspirin / butalbital / caffeine Pregnancy and Breastfeeding Warnings

Aspirin / butalbital / caffeine is also known as: Butalbital Compound, Farbital, Fiorinal, Fiormor, Fiortal, Fortabs, Idenal, Laniroif

Aspirin / butalbital / caffeine Pregnancy Warnings

Use is not recommended unless clearly needed US FDA pregnancy category: C Comment: -Monitor for barbiturate withdrawal in neonates

Animal reproduction studies have not been conducted with this combination product. Barbiturates have been reported to readily cross the placental barrier. A 2-day old infant whose mother had taken a butalbital-containing product during the last two months of pregnancy experienced withdrawal seizures; butalbital was found in the infant's serum. Aspirin has not been associated with an increased risk of abnormalities when taken during the first trimester of pregnancy; therapeutic doses of aspirin close to term may cause bleeding in mother, fetus, or neonate. There are no controlled data on this combination product in human pregnancy. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Aspirin / butalbital / caffeine Breastfeeding Warnings

Aspirin, butalbital, and caffeine are excreted into human milk in small concentrations. The significance of the effects on nursing infants has not been reported, but due to the potential for serious adverse reactions in nursing infants, other agents may be preferred.

A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Yes (aspirin); Yes (barbiturates); Yes (caffeine)

See references

References for pregnancy information

  1. "Product Information. Fiorinal (ASA/butalbital/caffeine)" Actavis (formerly Abrika Pharmaceuticals LLP), Sunrise, FL.
  2. "Product Information. Aspirin/Butalbital/Caffeine (aspirin/butalbital/caffeine (acetylsalicylic acid/butalbital/caffeine))." Major Pharmaceuticals Inc, Livonia, MI.

References for breastfeeding information

  1. "Product Information. Aspirin/Butalbital/Caffeine (aspirin/butalbital/caffeine (acetylsalicylic acid/butalbital/caffeine))." Major Pharmaceuticals Inc, Livonia, MI.
  2. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL:" ([cited 2013 -]):
  3. "Product Information. Fiorinal (ASA/butalbital/caffeine)" Actavis (formerly Abrika Pharmaceuticals LLP), Sunrise, FL.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.